HCPCS U0001: CDC 2019 Novel Coronavirus RT-PCR Diagnostic Panel - OpenPayer

Summary & Overview

HCPCS U0001: CDC 2019 Novel Coronavirus RT-PCR Diagnostic Panel

HCPCS Level II code U0001 designates the CDC 2019 novel coronavirus (2019-nCoV) real-time RT-PCR diagnostic panel, a molecular test used to detect SARS-CoV-2 RNA. Nationally, this code has been central to pandemic response efforts by enabling standardized billing and tracking for a high-volume diagnostic service critical to case identification, public health surveillance, and clinical decision-making.

Analysis covers major national payers: Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise briefing on payer coverage considerations, common billing modifiers, and operational contexts for laboratories and hospital services. The publication outlines typical sites of service and the clinical applicability of the assay, and highlights what national stakeholders consider when processing claims for this test.

This summary provides benchmarks and policy context relevant to payers and providers, including coding purpose, typical service workflows, and areas where payers and laboratories frequently address coverage, documentation, and claim adjudication. Data not available in the input for specific payer policies, reimbursement rates, or claim-level metrics are noted where applicable.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicareU0001HCPCS Level IISARS-CoV-2 testingRT-PCRmolecular diagnosticslaboratory testCOVID-19diagnostic coding

Billing Code Overview

HCPCS Level II code U0001 represents the CDC 2019 novel coronavirus (2019-nCoV) real-time RT-PCR diagnostic panel. This code is used to report laboratory testing that detects the presence of SARS-CoV-2 viral RNA using a real-time reverse transcription polymerase chain reaction (RT-PCR) assay developed by the Centers for Disease Control and Prevention.

Service type: Diagnostic molecular laboratory test (real-time RT-PCR).

Typical site of service: Clinical laboratories, hospital laboratories, public health laboratories, and other certified laboratory facilities performing molecular diagnostic testing.

Clinical & Coding Specifications

Clinical Context

A symptomatic adult presents to an urgent care clinic with fever, cough, and shortness of breath during a period of community spread of SARS-CoV-2. The clinician performs a focused evaluation, documents travel and exposure history, and determines molecular testing is indicated. A nasopharyngeal swab is collected by a licensed clinician or trained staff and sent to a laboratory capable of running the CDC 2019 novel coronavirus real-time RT-PCR diagnostic panel billed with U0001. Specimen handling includes labeling, appropriate transport media, and chain-of-custody documentation. The laboratory performs nucleic acid extraction and real-time RT-PCR targeting SARS-CoV-2 genomic sequences and reports results to the ordering clinician for isolation and treatment decisions. Typical sites of service include outpatient clinics, urgent care centers, emergency departments, and public health laboratories.

Coding Specifications

Modifier	Description	When to Use
`00`	No modifier applicable (default)	Use when no specific modifier applies to the service billed with `U0001`.
`25`

HCPCS U0002: SARS-CoV-2 Multi-Target Molecular Test (Non-CDC)

Taxonomy Code	Specialty	Notes
`207Q00000X`	Infectious Disease (Physician)	Physicians who order and interpret complex molecular infectious disease testing.
`261QM0800X`	Clinical Laboratory Scientist/Technologist	Professionals who perform molecular diagnostic testing in the lab.
`363A00000X`	Pathology/Laboratory Medicine	Laboratories and pathologists overseeing testing quality and result interpretation.
`208000000X`	Emergency Medicine	Clinicians in EDs who commonly order SARS-CoV-2 RT-PCR testing.
`208D00000X`	Family Medicine	Primary care and urgent care providers who collect specimens and order testing.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`J12.82`	Pneumonia due to coronavirus	Indicates lower respiratory tract infection with coronavirus; justifies molecular testing for SARS-CoV-2.
`U07.1`	COVID-19	Confirms diagnosis of COVID-19; used when testing is performed for suspected or confirmed infection.
`R05`	Cough	Symptom prompting diagnostic testing for respiratory pathogens including SARS-CoV-2.
`R50.9`	Fever, unspecified	Fever is a common symptom leading to ordering of SARS-CoV-2 RT-PCR.
`Z20.828`	Contact with and (suspected) exposure to other viral communicable diseases	Used when testing is performed due to known exposure to a COVID-19 case.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`87631`	Infectious agent detection by nucleic acid (DNA or RNA); SARS-CoV-2, amplified probe technique	Commonly used as an alternative or follow-up molecular assay for SARS-CoV-2 detection; may be billed when platform-specific CPT is appropriate.
`87641`	Infectious agent detection by nucleic acid (DNA or RNA); multiple types/targets, 1-2 targets	Used for multiplex respiratory panels that include SARS-CoV-2 and other viral targets; relates when broader panels are performed instead of a single-target PCR.
`99213`	Office or other outpatient visit for evaluation and management of an established patient, typically 15 minutes	Typical E/M level billed when a clinician evaluates symptoms and orders the RT-PCR test the same day.
`99000`	Handling and/or conveyance of specimen for transfer from office to another lab (specimen handling)	Billed when a provider charges for special specimen handling and transport associated with testing.
`G2023`	Specimen collection for SARS-CoV-2 viral testing, required ancillary service, HCPCS G-code	Used by some payers to report specimen collection for COVID-19 testing when applicable; billed in conjunction with molecular test.

OpenPayer